Pathogenic microbes, the microbiome, and Alzheimer's disease (AD)

Frontiers in Aging Neuroscience

Volumn 6, Issue JUN, 2014, Pages

  Hill, James M ^a,b   Clement, Christian ^a   Pogue, Aileen I ^c   Bhattacharjee, Surjyadipta ^b   Zhao, Yuhai ^b   Lukiw, Walter J ^a,b,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Alchem Biotek Corporation   (Canada)

Author keywords

Alzheimer's disease; Microbiome; Prion, miRNA; Virus replication

Indexed keywords

AMYLOID BETA PROTEIN; MICRORNA;

AGE; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CHLAMYDOPHILA PNEUMONIAE; COGNITIVE DEFECT; CYTOMEGALOVIRUS; DEMENTIA; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENETIC ASSOCIATION; HEPATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIOME; MICROORGANISM; MYCOSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PHENOTYPE; PRION DISEASE; RISK FACTOR; SENILE PLAQUE; SIGNAL TRANSDUCTION; TOXOPLASMA; VIROID;

EID: 84904567340     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00127     Document Type: Article

References (58)

1. Agostini, S., Clerici, M., and Mancuso, R. (2014). How plausible is a link between HSV-1 and AD? Expert Rev. Anti. Infect. Ther. 12, 275-278. doi: 10.1586/14787210.2014.887442
2. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2012). microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
3. Alonso, R., Pisa, D., Marina, A. I., Morato, E., Rábano, A., and Carrasco, L. (2014). Fungal infection in patients with Alzheimer's disease. J. Alzheimers Dis. 41, 301-311. doi: 10.3233/JAD-132681
4. Asti, A., and Gioglio, L. (2014). Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimers. Dis. 39, 169-179. doi: 10.3233/JAD-131394
5. Balin, B. J., and Hudson, A. P. (2014). Etiology and pathogenesis of AD. Curr. Allergy Asthma Rep. 14, 417. doi: 10.1007/s11882-013-0417-1
6. Ball, M. J., Lukiw, W. J., Kammerman, E. M., and Hill, J. M. (2012). Intracerebral propagation of AD: strengthening evidence of an HSV-1 etiology. Alzheimers Dement. 9, 169-175. doi: 10.1016/j.jalz.2012.07.005
7. Bhattacharjee, S., and Lukiw, W. J. (2013). Alzheimer's disease and the microbiome. Front. Cell. Neurosci. 7:153. doi: 10.3389/fncel.2013.00153
8. Borjabad, A., and Volsky, D. J. (2012). Common transcriptional signatures in brain from patients with HIV-associated neurocognitive disorders, Alzheimer's, and multiple sclerosis. J. Neuroimmune. Pharmacol. 7, 914-926. doi: 10.1007/s11481-012-9409-5
9. Boutajangout, A., and Wisniewski, T. (2013). The innate immune system in AD. Int. J. Cell. Biol. 2013:576383. doi: 10.1155/2013/576383
10. Bravo, J. A., Julio-Pieper, M., Forsythe, P., Kunze, W., Dinan, T. G., Bienenstock, J., et al. (2012). Communication between gastrointestinal bacteria and the nervous system. Curr. Opin. Pharmacol. 12, 667-672. doi: 10.1016/j.coph.2012.09.010
11. Brenner, S. R. (2013). Blue-green algae or cyanobacteria in the intestinal micro-flora my produce neurotoxins such as beta-N-methylamino-L-alanine which may be related to development of amyotrophic lateral sclerosis, AD and Parkinsons-dementia-complex. Med. Hypotheses. 80, 103-108. doi: 10.1016/j.mehy.2012.10.010
12. Chen, B., Soto, C., and Morales, R. (2014). Peripherally administrated prions reach the brain at sub-infectious quantities. FEBS Lett. 588, 795-800. doi: 10.1016/j.febslet.2014.01.038
13. Chiu, W. C., Tsan, Y. T., Tsai, S. L., Chang, C. J., Wang, J. D., Chen, P. C., et al. (2013). Hepatitis C viral infection and the risk of dementia. Eur. J. Neurol. doi: 10.1111/ene.12317. [Epub ahead of print].
14. Cho, I., and Blaser, M. J. (2012). The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260-270. doi: 10.1038/nrg3182
15. Choroszy-Król, I., Frej-Madrzak, M., Hober, M., Sarowska, J., and Jama-Kmiecik, A. (2014). Infections caused by Chlamydophila pneumoniae. Adv. Clin. Exp. Med. 23, 123-126.
16. Cross, D. J., Anzai, Y., Petrie, E. C., Martin, N., Richards, T. L., Maravilla, K. R., et al. (2013). Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J. Nucl. Med. 54, 1278-1284. doi: 10.2967/jnumed.112.116558
17. Danborg, P. B., Simonsen, A. H., Waldemar, G., and Heegaard, N. H. (2014). The potential of microRNAs as biofluid markers of neurodegenerative diseases-a systematic review. Biomarkers 19, 259-268. doi: 10.3109/1354750X.2014.904001
18. Douglas-Escobar, M., Elliott, E., and Neu, J. (2013). Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr. 167, 374-379. doi: 10.1001/jamapediatrics.2013.497
19. Foster, J. A., and McVey Neufeld, K. A. (2013). Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36, 305-312. doi: 10.1016/j.tins.2013.01.005
20. Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., and Balin B. (2010). Immunohistological detection of Chlamydia pneumoniae in Alzheimer's disease. BMC Neurosci. 11:121. doi: 10.1186/1471-2202-11-121
21. Heintz, C., and Mair, W. (2014). You are what you host: microbiome modulation of the aging process. Cell 156, 408-411. doi: 10.1016/j.cell.2014.01.025
22. Hernandez-Rapp, J., Martin-Lannerée, S., Hirsch, T. Z., Launay, J. M., and Mouillet-Richard, S. (2014). Hijacking PrP(c)-dependent signal transduction: when prions impair Aß clearance Front. Aging Neurosci. 6:25. doi: 10.3389/fnagi.2014.00025
23. Hill, J. M., and Lukiw, W. J. (2014). Comparing miRNAs and viroids; highly conserved molecular mechanisms for the transmission of genetic information. Front. Cell Neurosci. 8:45. doi: 10.3389/fncel.2014.00045
24. Hill, J. M., Zhao, Y., Bhattacharjee, S., and Lukiw, W. J. (2014). miRNAs and viroids utilize common strategies in genetic signal transfer. Front. Mol. Neurosci. 7:10. doi: 10.3389/fnmol.2014.00010
25. Hill, J. M., Zhao, Y., Clement, C., Neumann, D. M., and Lukiw, W. J. (2009). HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 20, 1500-1505. doi: 10.1097/WNR.0b013e3283329c05
26. Hornig, M. (2013). The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr. Opin. Rheumatol. 25, 488-795. doi: 10.1097/BOR.0b013e32836208de
27. Huang, W. S., Yang, T. Y., Shen, W. C., Lin, C. L., Lin, M. C., and Kao, C. H. (2014). Association between Helicobacter pylori infection and dementia. J. Clin. Neurosci. doi: 10.1016/j.jocn.2013.11.018. [Epub ahead of print].
28. Huston, W. M., Barker, C. J., Chacko, A., and Timms, P. (2014). Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae. J. Bacteriol. 196, 1915-1924. doi: 10.1128/JB.01476-14
29. Itzhaki, R. F., and Wozniak, M. A. (2008). Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J. Alzheimers Dis. 13, 393-405.
30. Jamieson, G. A., Maitland, N. J., Craske, J., Wilcock, G. K., and Itzhaki, R. F. (1991). Detection of HSV-1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction. Biochem. Soc Trans. 19:122S.
31. Kammerman, E. M., Neumann, D. M., Ball, M. J., Lukiw, W., and Hill, J. M. (2006). Senile plaques in Alzheimer's disease: possible association of beta-amyloid with HSV-1 L-particles. Med. Hypotheses. 66, 294-299. doi: 10.1016/j.mehy.2005.07.033
32. Karim, S., Mirza, Z., Kamal, M. A., Abuzenadah, A. M., Azhar, E. I., Al-Qahtani, M. H., et al. (2014). An association of virus infection with type 2 diabetes and Alzheimer's disease. CNS Neurol. Disord. Drug Targets 13, 429-439. doi: 10.2174/18715273113126660164
33. Kim, B. S., Jeon, Y. S., and Chun, J. (2013). Current status and future promise of the human microbiome. Pediatr. Gastroentero.l Hepatol. Nutr. 16, 71-79. doi: 10.5223/pghn.2013.16.2.71
34. Lazarov, O., and Marr, R. A. (2010). Neurogenesis and Alzheimer's disease: at the crossroads. Exp. Neurol. 223, 267-281. doi: 10.1016/j.expneurol.2009.08.009
35. Liu, W. T., Lin, S. C., Chou, W. I., Liu, T. H., Pan, R. L., Tzou, D. L., et al. (2008). Identification and characterization of a novel fibril forming peptide in fungal starch binding domain. Biochem. Biophys. Res. Commun. 377, 966-970. doi: 10.1016/j.bbrc.2008.10.085
36. Lukiw, W. J., Cui, J. G., Yuan, L. Y., Bhattacharjee, P. S., Corkern, M., Clement, C., et al. (2010). Acyclovir or Aß 42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport 21, 922-927. doi: 10.1097/WNR.0b013e32833da51a
37. Lukiw, W. J., Dua, P., Pogue, A. I., Eicken, C., and Hill, J. M. (2011). Upregulation of miRNA-146a, a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease and Gerstmann-Straussler-syndrome. J. Toxicol. Environ. Health 74, 1460-1468. doi: 10.1080/15287394.2011.618973
38. Lukiw, W. J. (2013). Variability in miRNA abundance, speciation and complexity amongst different human populations and potential relevance to AD. Front. Cell Neurosci. 7:133. doi: 10.3389/fncel.2013.00133
39. Lurain, N. S., Hanson, B. A., Martinson, J., Leurgans, S. E., Landay, A. L., Bennett, D. A., et al. (2013). Virological and immunological characteristics of human cytomegalovirus infection associated with AD. J. Infect. Dis. 208, 564-572. doi: 10.1093/infdis/jit210
40. Maffioletti, E., Tardito, D., Gennarelli, M., and Bocchio-Chiavetto, L. (2014). Micro spies from the brain to the periphery: new clues from studies on miRNAs in neuropsychiatric disorders. Front. Cell. Neurosci. 8:75. doi: 10.3389/fncel.2014.00075
41. Mancuso, R., Baglio, F., Cabinio, M., Calabrese, E., Hernis, A., Nemni, R., et al. (2014). Titers of HSV-1 antibodies correlate with grey matter volumes in AD. J. Alzheimers Dis. 38, 741-745 doi: 10.3233/JAD-130977
42. Miklossy, J. (2011). Emerging roles of pathogens in AD. Expert Rev. Mol. Med. 13:e30. doi: 10.1017/S1462399411002006
43. Monaco, S., Ferrari, S., Gajofatto, A., Zanusso, G., and Mariotto, S. (2012). HCV-related nervous system disorders. Clin. Dev. Immunol. 2012:236148. doi: 10.1155/2012/236148
44. Navarro, B., Gisel, A., Rodio, M. E., Delgado, S., Flores, R., and Di Serio, F. (2012). Viroids: how to infect a host and cause disease without encoding proteins. Biochimie 94, 1474-1480. doi: 10.1016/j.biochi.2012.02.020
45. Plaisance-Bonstaff, K., and Renne, R. (2011). Viral miRNAs. Methods Mol. Biol. 721, 43-66. doi: 10.1007/978-1-61779-037-9_3
46. Pogue, A. I., Hill, J. M., and Lukiw, W. J. (2014). MicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNS. Brain Res. doi: 10.1016/j.brainres.2014.03.042. [Epub ahead of print].
47. Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., and Crean, S. (2013). Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J. Alzheimers Dis. 36, 665-677. doi: 10.3233/JAD-121918
48. Prandota, J. (2014). Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am. J. Alzheimers Dis. Other Demen. 29, 205-214. doi: 10.1177/1533317513517049
49. Prusiner, S. B. (2013). Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 47, 601-623. doi: 10.1146/annurev-genet-110711-155524
50. Risacher, S. L., and Saykin, A. J. (2013). Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin. Neurol. 33, 386-416. doi: 10.1055/s-0033-1359312
51. Stöhr, J., Watts, J. C., Mensinger, Z. L., Oehler, A., Grillo, S. K., DeArmond, S. J., et al. (2012). Purified and synthetic Alzheimer amyloid prions. Proc. Natl. Acad. Sci. U.S.A. 109, 11025-11030. doi: 10.1073/pnas.1206555109
52. Toma, H. S., Murina, A. T., Areaux, R. G., Neumann, D. M., Bhattacharjee, P. S., Foster, T. P., et al. (2008). HSV-1 latency, reactivation and recurrent disease. Semin. Ophthalmol. 23, 249-273. doi: 10.1080/08820530802111085
53. Tran, L., and Greenwood-Van Meerveld, B. (2013). Age-associated remodeling of the intestinal epithelial barrier. J. Gerontol. A Bio.l Sci. Med. Sci. 68, 1045-1056. doi: 10.1093/gerona/glt106
54. Welling, M. M., Nabuurs, R. J., and van der Weerd, L. (2014). Potential role of antimicrobial peptides in the early onset of Alzheimer's disease. Alzheimers Dement. doi: 10.1016/j.jalz.2013.12.020. [Epub ahead of print].
55. Whitman, W. B., Coleman, D. C., and Wiebe, W. J. (1998). Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. U.S.A. 95, 6578-6583. doi: 10.1073/pnas.95.12.6578
56. Widera, M., Klein, A. N., Cinar, Y., Funke, S. A., Willbold, D., and Schaal, H. (2014). The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity. AIDS Res. Ther. 11:1. doi: 10.1186/1742-6405-11-1
57. Wunderink, R. G., and Waterer, G. W. (2014). Clinical practice: community-acquired pneumonia. N. Engl. J. Med. 370, 543-551. doi: 10.1056/NEJMcp1214869
58. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227. doi: 10.1038/nature11053